Authors


Jerry A. Barbee Jr.

Latest:

5 Tips for Securing a Residency

With Midyear approaching, many are dreaming of finding that perfect program. Now is the time to start coming up with a game plan.


Jaclyn D. Cole, PharmD, BCPS

Latest:

Drug Review: Daklinza for Chronic Hepatitis C Infection

An overview of Daklinza (daclatasvir) for pharmacists.


Caitlyn Tompkins

Latest:

CAR-NK Cell Immunotherapy Shows Promise

Patients with relapsed or refractory lymphomas may benefit from CAR-NK cell immunotherapy and Have fewer adverse events.


Brooke L. Griffin, PharmD

Latest:

The Road Less Traveled: Nontraditional Work Arrangements in Academia

According to the 2014 National Pharmacist Workforce Study, approximately 18.7% of women and 16.4% of men actively engaged as pharmacists reported working part-time.


Jerry Barbee, Jr, PharmD, BCPS

Latest:

HIV/AIDS: Curbing the Epidemic

Medications enable the management of HIV.


Jonathan D. Campbell, PhD

Latest:

Managed Care Plans to Support Evidence-Based Guidelines for Asthma

Examining new and emerging therapies to meet the unmet needs of patients with asthma.


R.

Latest:

Utility of the PhaSeal Closed System Drug Transfer Device

The Phaseal closed system drug transfer device provides a mechanical barrier to the entry of contaminants into sterile solutions for up to 168 hours.


Samuel P. Sutherland, BS

Latest:

Resource Use Among Nonvalvular Atrial Fibrillation Patients

This study assesses comparative resource use for patients given a new diagnosis of nonvalvular atrial fibrillation treated with dabigatran or warfarin in a real-world setting.


Tony Berberabe, MPH

Latest:

Specialty Pharmacy Makes Inroads in Urology Practice

Increasing number of urology practices working with specialty pharmacies.



Ryan Moore, PharmD, MS

Latest:

mPharm: The Pharmacist as a Health Information Solution Provider

Pharmacists can employ new tools to educate and engage patients while maximizing outcomes.


Peggy Piascik, PhD, BSPharm

Latest:

Understanding and Managing Rosacea in Your Pharmacy

This Continuing Education activity has been supported by an educational grant from Bayer HealthCare Pharmaceuticals Inc.


Alesia Sadosky, PhD

Latest:

Pregabalin Prior Authorization and Potential Medication-Medication and Medication-Condition Interactions

This study of patients treated with pregabalin or duloxetine found that pregabalin prior authorization policies were associated with increased exposure to potential medication-medication and medication-condition interactions.


David R. Lairson, PhD

Latest:

Cost-Utility Analysis of Treatments for Advanced Non-Small Cell Lung Cancer

A national community-level study of Medicare patients with advanced non-small cell lung cancer found that adding targeted therapy to chemotherapy regimens was not cost-effective.




Shin-Pung Jen, PharmD, BCPS-AQ ID, AAHIVP

Latest:

It Is a "VRE" Serious Controversy

What are the advantages and disadvantages of linezolid versus daptomycin for vancomycin-resistant enterococcus bacteremia?


Antonio C. Bossi, MD

Latest:

Potential Gender Differences of Exenatide in Outpatients With Type 2 Diabetes Mellitus

In outpatients with type 2 diabetes mellitus, persistent exenatide treatment lowered glycated hemoglobin and hyperglycemia in both genders. Waist circumference and body weight were more reduced in women.



Joseph J. Saseen, PharmD, BCPS

Latest:

Successful Collaborative Care Strategies for Pharmacists

The panel concludes its discussion with insights on successful strategies that can inform optimal collaborative care practices for cardiovascular risk reduction in patients with ASCVD.


Kristen Coppock

Latest:

First Oral Tablet for Chemotherapy-induced Diarrhea in Dogs Receives Conditional FDA Approval

The prescription-only crofelemer delayed-release tablets were developed using a sustainable, plant-based formula.



Andrew Layton, BA

Latest:

Cost-Effectiveness of Extended-Release Carbidopa-Levodopa for Advanced Parkinson's Disease

Existing levodopa therapies for Parkinson’s disease often provide inadequate symptom control after prolonged treatment. This study assessed the cost-effectiveness of an extended-release carbidopa-levodopa formulation (IPX066).


John Fiacco, RPh

Latest:

From Pharmacist to Entrepreneur: Pursuing a Career in Pharmacy Ownership

As a pharmacy student, it is easy to see yourself working behind the counter at a major chain store when you think about your future.


Gregory Hamby, PharmD, RPh

Latest:

Using Patient-management Software for Improved Care

The pharmacist's role is changing from a technical function.


Nila Carpenter, LPN

Latest:

Exploring Nursing Adherence Programs for Oral Oncolytics

Specialty pharmacies are becoming more involved in programs that focus on the management of oral oncolytics. The role of health care workers, including pharmacists, physicians, and nurses, is being defined as this therapeutic class grows.



Shaul Eitan

Latest:

Devices, Not Just Doctors, Should Engage Patients

But many products are designed for medical professionals, not consumers, and that needs to change.


Samuel Stolpe, PharmD, MPH

Latest:

Year-Round Solutions Beyond the Influenza Season

As the margin between acquisition cost and sales price continues to narrow for traditional community pharmacy medication dispensing, many pharmacies are increasingly turning to service-based opportunities to improve their profitability.


Miley G. Nikirk, PharmD Candidate

Latest:

Legal Issues With Naloxone Availability Conferring Authority and Insulating From Liability

The rise of opioid overdoses nationally has expanded the role of pharmacists and advocacy for pharmacists to apply their knowledge and talents to emergency situations.